GILD Gilead Sciences, Inc.

$143.72▼ -0.75% Healthcare Other
After hours $143.58▼ -0.10% Sep 11, 7:30 PM ET
Volume 4.19M Avg Volume (10D) 5.27M
Key Metrics & Fundamentals
Market Cap
$178.21B
P/E Ratio
18.4
Div Yield
2.27%
52W Range
108.46 - 157.29
% vs 50 MA
5.14%
% vs 200 MA
7.55%
RSI-14
52.8
MACD Histogram
-0.6900
Beta (1Y vs SPY)
0.34
Free Cash Flow
$3.43B
Gross Rev
$7.80B
Gross Profit
$6.22B
EBITDA
$3.28B
COGS
$1.58B
Operating Exp
$3.69B
Operating Income
$2.54B
EBIT
$2.54B
Pretax Income
-$10.25B
Net Income
-$10.50B
EPS (Diluted)
-8.45
Price & Volume History
Loading chart…
Recent News
Gilead Wins Appeals Court Ruling Blocking Imported HIV Drug Sales
Insider Monkey · Sep 11, 2026 8:52 PM
Gilead Sciences Sees Sunlenca Launch Fueling Long-Term HIV Growth
MarketBeat · Sep 10, 2026 4:02 PM
HSBC Adjusts Price Target on Gilead Sciences to $175 From $155, Keeps Buy Rating
MT Newswires · Sep 10, 2026 10:09 AM
Gilead Sciences Eyes HIV, Oncology Catalysts as Pipeline Enters Execution Mode
MarketBeat · Sep 10, 2026 4:02 AM
Sofinnova Investments Announces the Appointment of Dr. Merdad Parsey as Executive Partner
Business Wire · Sep 9, 2026 3:00 PM
1 S&P 500 Stock on Our Buy List and 2 Facing Challenges
StockStory · Sep 9, 2026 1:54 PM
Gilead launches research facility in US for new medicine development
Pharmaceutical Technology · Sep 9, 2026 10:59 AM
Gilead Sciences (GILD) Suffers a Larger Drop Than the General Market: Key Insights
Zacks · Sep 8, 2026 9:50 PM
Assembly Biosciences Exercises Option to Share US Costs, Profits for Herpes Program With Gilead
MT Newswires · Sep 8, 2026 9:14 PM
Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for HSV Helicase-Primase Inhibitor Program
GlobeNewswire · Sep 8, 2026 8:00 PM
Financial Overview - Income Statement Quarterly

See GILD's money flow as a full page

Social Sentiment
Avg -0.10 · 11 posts
DiscussionDefensive stocks ideas as we enter AI bubble?
r/investing · Oct 9, 2025
Mentioned as a core component of a defensive strategy.
positive +0.50
NewsDiscussion$GILD drops MASH drugs
r/StockMarket · Aug 9, 2025
Gilead’s pipeline is being significantly impacted, leading to a negative outlook.
negative -0.50
TradeBig buys in the June 2027 Contracts
r/options · May 13, 2025
Call purchases signal a bullish outlook on GILD.
positive +0.60
NewsDiscussionTradeNext week's big pharma drug pricing crackdown rumors
r/options · May 9, 2025
Discussion of potential impact due to drug pricing crackdown rumors.
negative -0.30
EarningsNewsTgif. Watchlist
r/StockMarket · Apr 25, 2025
Shares dropped due to mixed results and reduced guidance, indicating negative sentiment.
negative -0.80
Page 1 of 3 (11 total)
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙